Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes

Loading...
Thumbnail Image

Date

Authors

Mullbacher, Arno
Waring, Paul
Tha Hla, Ron
Tran, Thao (Thomas)
Chin, S
Stehle, Thomas
Museteanu, Crisan
Simon, Markus M

Journal Title

Journal ISSN

Volume Title

Publisher

National Academy of Sciences (USA)

Abstract

Analysis of perforin-deficient mice has identified the cytolytic pathway and perforin as the preeminent effector molecule in T cell-mediated control of virus infections. In this paper, we show that mice lacking both granzyme A (gzmA) and granzyme B (gzmB), which are, beside perforin, key constituents of cytolytic vesicles, are as incapable as are perforin-deficient mice of controlling primary infections by the natural mouse pathogen ectromelia, a poxvirus. Death of gzmA x gzmB double knockout mice occurred in a dose- dependent manner, despite the expression of functionally active perforin and the absence of an intrinsic defect to generate splenic cytolytic T cells. These results establish that both gzmA and gzmB are indispensable effector molecules acting in concert with perforin in granule exocytosis-mediated host defense against natural viral pathogens.

Description

Citation

Source

PNAS - Proceedings of the National Academy of Sciences of the United States of America

Book Title

Entity type

Access Statement

License Rights

Restricted until

2037-12-31